Development of hepatocellular carcinoma after sustained response to interferon therapy: how long should sustained responders with risk factors be followed?
Kasahara
Akinori
A
D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology* / Q000517:prevention & control; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007372:Interferons; D008113:Liver Neoplasms / Q000453:epidemiology* / Q000517:prevention & control; D012074:Remission Induction; D012307:Risk Factors; D013997:Time Factors
D000998:Antiviral Agents; D007372:Interferons